Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates

Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024

Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review

Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.01, revenue of $1.53M misses by $1.19M

Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?

Arbutus Biopharma Announces Q1 2024 Financial Update

Arbutus Biopharma Announces Q1 2024 Financial Update

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

Arbutus Biopharma Wins Favorable Ruling Against Moderna

Arbutus Biopharma Wins Favorable Ruling Against Moderna

Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna

Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna

Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)

Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)

Moderna shares fall after judge sides with Arbutus in patent fight